CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Mega Genomics Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Mega Genomics Ltd
401 Health Work
North Garden Road, Haidian District
BEIJING, BEJ  China Ticker: 66676667
Business Summary
Mega Genomics Ltd is an investment holding company primarily engaged in the provision of genetic testing and cancer screening services. The Company mainly operates it business through two segments. The Consumer Genetic Testing Services segment is engaged in providing brain health assessment package, alimentation capability assessment package, Parkinson’s disease risk assessment, whole exome sequencing package for adult and others. The Cancer Screening Services segment is engaged in providing Alzheimer’s disease screening kits, colorectal cancer screening kits, gastric cancer screening kits, lung nodule auxiliary diagnostic kits and cervical cancer screening kits. The Company mainly conducts its business in the domestic market.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
6/30/202412/31/2023-----

Industries
SIC Code Description
8071 Medical laboratories
8731 Commercial physical and biological research
6719 Offices of holding companies, not elsewhere classified

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Executive Chairman of the Board LinLin 49 8/6/2021 4/22/2021
Chief Financial Officer, Executive Director JingJiang 41 8/6/2021 11/24/2020
Executive Director, Honorary Co-Chairperson RongYu 49 8/6/2021 8/6/2021
9 additional Officers and Directors records available in full report.

General Information
Number of Employees: 214 (As of 6/30/2024)
Outstanding Shares: 224,300,200 (As of 3/28/2025)
Stock Exchange: HKG


Copyright © 2025 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Sunday, August 10, 2025